Coevolution with viruses drives the evolution of bacterial mutation ratesCsaba Pál, Angus Buckling, María D. Macià et al.|Nature|2007Cited by 331
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Tomas Hruby, Bruno François et al.|Critical Care|2022Cited by 93